Envoy Therapeutics, Inc.
Records under this name other than patents Envoy Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Envoy Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,670,229 | 5-HT3 Receptor Antagonists conveyed to Takeda Pharmaceutical Company Limited In force · Medium confidence | In force | Medium confidence | |
| US 10,125,145 | 5-HT3 Receptor Antagonists conveyed to Takeda Pharmaceutical Company Limited In force · Medium confidence | In force | Medium confidence | |
| US 10,407,443 | 5-HT3 Receptor Antagonists conveyed to Takeda Pharmaceutical Company Limited In force · Medium confidence | In force | Medium confidence | |
| US 9,012,447 | 5-HT3 Receptor Antagonists now held by Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 9,487,526 | Quinoxaline Derivatives as GPR6 Modulators now held by Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 9,770,452 | Quinoxaline Derivatives as GPR6 Modulators conveyed to Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 9,181,249 | SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS conveyed to Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 10,077,266 | SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS conveyed to Takeda Pharmaceutical Company Limited In force · Low confidence | In force | Low confidence | |
| US 10,738,046 | Substituted Pyrido[3,4-b]pyrazines as GPR6 Modulators conveyed to Takeda Pharmaceutical Company Limited In force · Low confidence | In force | Low confidence | |
| US 9,708,313 | SUBSTITUTED PYRIDO[3,4-b]PYRAZINES AS GPR6 MODULATORS conveyed to Takeda Pharmaceutical Company Limited In force · Medium confidence | In force | Medium confidence |